Last edition
News about Regulation
MEDITECH STACKATHON 2024 Launched to Propel India's MedTech Sector Towards Innovation
Dr. Chawla emphasized the immense potential of India's MedTech industry, projecting a growth rate of 28 percent annually, with estimates indicating a market size of USD 50 billion by 2030.
Regulation | 08/05/2024 | By Abha | 328
Government Unveils Upgraded Pharmaceuticals Scheme to Boost Industry Standards
The revised scheme, a significant step in the government's efforts, follows a comprehensive review by the Scheme Steering Committee.
Regulation | 12/03/2024 | By Abha | 181
With an investment of more than Rs 600 Crores, the project includes the construction of the medical college, hospital, and related buildings, dedicated to enhancing healthcare services for tribal communities and the wider population of Nandurbar and is expected to be completed by February 2026.
Regulation | 27/02/2024 | By Manvi | 346
Union Minister Launches Nationwide MDA Campaign to Combat Lymphatic Filariasis
The campaign, covering 92 districts across 11 states, will span the next two weeks.
Regulation | 10/02/2024 | By Manvi | 251
India's Ministry of Health Revises Pharmaceutical Manufacturing Rules
The move is seen as a step towards aligning with international quality standards and ensuring the production of safe and high-quality drugs.
Regulation | 08/01/2024 | By Manvi | 501
Union Cabinet has already approved the National Policy on Research and Development and Innovation in the Pharma-Med Tech Sector in India.
Regulation | 30/08/2023 | By Manvi | 550
USFDA Conducts Pre-Market Inspection at Pashamylaram Facility of Gland Pharma
The Company is committed to address the observations and will submit its response to USFDA within the stipulated time.
Regulation | 28/08/2023 | By Manvi | 411
Gland Pharma Receives EIR From USFDA For Dundigal Facility
Gland Pharma shares gained nearly 3 percent in trade after receiving EIR.
Regulation | 25/08/2023 | By Manvi | 477
Torrent Pharmaceuticals Receives EIR from USFDA for Dahej Facility
The Dahej facility was placed under OAI by the USFDA based on the March 2019 Inspection outcome.
Regulation | 25/08/2023 | By Manvi | 734
Glenmark Pharma settles drug pricing case with US Department of Justice
Glenmark Pharma settles drug pricing case with US Department of Justice
Regulation | 24/08/2023 | By Sudeep Soparkar | 343
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy